Cite Filings / INKT / 0000950170-23-021191
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
10-Q

Quarterly Report

MiNK Therapeutics, Inc. · Filed 2023-05-11 · Acc 0000950170-23-021191

Documents 1

  • 10-Q Quarterly Report , inkt-20230331.htm

Around this filing

  • 2023-08-10 10-Q Quarterly Report
  • 2023-05-12 4 10% owner bought 45,426 shares at an average $1.47 ($66,644)
  • 2023-05-11 8-K Results of operations
  • 2023-05-11 10-Q Quarterly Report
  • 2023-05-05 4 Director sold 100,000 shares at $0.95 ($94,850)
  • 2023-05-05 4 10% owner bought 250,362 shares at an average $1.04 ($260,189)
  • 2022-11-03 10-Q Quarterly Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
  • SEC Structured Data (opens in new tab)
Loading inkt-20230331.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…